Atrial fibrillation associated chromosome 4q25 variants are not associated with PITX2c expression in human adult left atrial appendages

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Gore Panter, Shamone R ^a,b   Hsu, Jeffery ^a,b   Hanna, Peter ^c   Gillinov, A Marc ^a   Pettersson, Gosta ^a   Newton, David W ^a   Moravec, Christine S ^a   Van Wagoner, David R ^a   Chung, Mina K ^a   Barnard, John ^a   Smith, Jonathan D ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; SPACER DNA;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHROMOSOME 4Q; CONTROLLED STUDY; DISEASE ASSOCIATION; ENPEP GENE; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PITX2 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CHROMOSOMES, HUMAN, PAIR 4; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; TRANSCRIPTION FACTORS;

EID: 84899790792     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086245     Document Type: Article

References (27)

1. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, et al. (2009) Prevention of atrial fibrillation: Report from a national heart, lung, and blood institute workshop. Circulation 119: 606-618.
2. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, et al. (2004) Lifetime risk for development of atrial fibrillation: The framingham heart study. Circulation 110: 1042-1046. (Pubitemid 39319000)
3. Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, et al. (2012) Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 44: 670-675.
4. Ellinor PT, Lunetta KL, Glazer NL, Pfeufer A, Alonso A, et al. (2010) Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 42: 240-244.
5. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, et al. (2007) Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448: 353-357. (Pubitemid 47080348)
6. Lubitz SA, Sinner MF, Lunetta KL, Makino S, Pfeufer A, et al. (2010) Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation 122: 976-984.
7. Cox CJ, Espinoza HM, McWilliams B, Chappell K, Morton L, et al. (2002) Differential regulation of gene expression by PITX2 isoforms. J Biol Chem 277: 25001.
8. Hsu J, Hanna P, Van Wagoner DR, Barnard J, Serre D, et al. (2012) Whole genome expression differences in human left and right atria ascertained by RNA SequencingClinical perspective. Circulation: Cardiovascular Genetics 5: 327-335.
9. Liu C, Liu W, Lu MF, Brown NA, Martin JF (2001) Regulation of left-right asymmetry by thresholds of Pitx2c activity. Development 128: 2039-2048. (Pubitemid 32605652)
10. Postma AV, Christoffels VM, Bezzina CR (2011) Developmental aspects of cardiac arrhythmogenesis. Cardiovasc Res 91: 243-251.
11. Lin CR, Kioussi C, O'Connell S, Briata P, Szeto D, et al. (1999) Pitx2 regulates lung asymmentry, cardiac positioning and pituitary and tooth morphogenesis. Nature 401: 279-281.
12. Wang J, Klysik E, Sood S, Johnson RL, Wehrens XHT, et al. (2010) Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proceedings of the National Academy of Sciences 107: 9753.
13. Schaub MA, Boyle AP, Kundaje A, Batzoglou S, Snyder M (2012) Linking disease associations with regulatory information in the human genome. Genome Res 22: 1748-1759.
14. Reich DE, Goldstein DB (2001) Detecting association in a case-control study while correcting for population stratification. Genet Epidemiol 20: 4-16.
15. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nature protocols 3: 1101-1108. (Pubitemid 351818697)
16. Liu H, Espinoza-Lewis RA, Chen C, Hu X, Zhang Y, et al. (2012) The role of Shox2 in SAN development and function. Pediatr Cardiol: 1-8.
17. Chinchilla A, Daimi H, Lozano-Velasco E, Dominguez JN, Caballero R, et al. (2011) PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. Circulation: Cardiovascular Genetics 4: 269-279.
18. Allessie M, Ausma J, Schotten U (2002) Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54: 230-246. (Pubitemid 34327903)
19. Barth AS, Merk S, Arnoldi E, Zwermann L, Kloos P, et al. (2005) Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: Expression of a ventricular-like genomic signature. Circ Res 96: 1022-1029. (Pubitemid 40712803)
20. Ausma J, Thone F, Dispersyn G, Flameng W, Vanoverschelde J, et al. (1998) Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant. Mol Cell Biochem 186: 159-168. (Pubitemid 28438558)
21. Thijssen VL, Ausma J, Borgers M (2001) Structural remodelling during chronic atrial fibrillation: Act of programmed cell survival. Cardiovasc Res 52: 14-24. (Pubitemid 32835235)
22. Blow MJ, McCulley DJ, Li Z, Zhang T, Akiyama JA, et al. (2010) ChIP-seq identification of weakly conserved heart enhancers. Nat Genet 42: 806-810.
23. Vazeux G, Wang J, Corvol P, Llorens-Cortès C (1996) Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A. J Biol Chem 271: 9069-9074. (Pubitemid 26123339)
24. Mitsui T, Nomura S, Okada M, Ohno Y, Kobayashi H, et al. (2003) Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice. Mol Med 9: 57-62. (Pubitemid 36667693)
25. Reaux A, Iturrioz X, Vazeux G, Fournie-Zaluski M, David C, et al. (2000) Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure. Biochem Soc Trans 28: 435-440.
26. Wright JW, Mizutani S, Harding JW (2012) Focus on brain angiotensin III and aminopeptidase A in the control of hypertension. International Journal of Hypertension 2012.
27. Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, et al. (2011) Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in East Asians. Nat Genet 43: 531-538.